Drug Development

Jyoti Mundlia is research scholar at PDM College of Pharmacy, Bahadurgarh, India

Rakesh Kumar Marwaha is associate professor at Maharshi Dayanand University's Department of Pharmacy

Articles

Box-Behnken modeling was used to optimize a resinate complex, to mask the taste of levocetirizine dihydrochloride and montelukast sodium in orally disintegrating tablets.

Using a Dual-Drug Resinate Complex for Taste Masking

Gyrolab CHO-HCP Kit 1 detects and quantifies host cell proteins from Chinese hamster ovary cells.

Kit Detects and Quantifies HCPs

The draft guidance document clarifies chemistry, manufacturing, and controls information for marketing applications.

FDA Releases Guidance on CMC Changes for Biologics

Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or biopolar I disorder.

Innovative Inhaled Antipsychotic Formulation Adasuve Provides Quick and Effective Treatment

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Pharmaceutical companies are constantly aiming for shorter drug-development cycles and advances in formulation development produce significant benefits.

Automation Saves Times and Reduces Cost in Formulation Development

This new pharmaceutical stability storage facility will enable the company to expand its analytical and formulation offerings to the pharmaceutical and biotech industries.

Intertek Opens GMP Pharmaceutical Stability Storage Facility in Cambridge, UK

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Widespread use and abuse of opioid painkillers is prompting efforts to develop new drugs and formulations that resist abuse while providing relief to legitimate patients.

Generic Opioids Create Policy Issues

Eight physician groups wrote to the commissioner of FDA to stress the importance of transparency in biosimilar labeling to decrease prescribing risks.

Physician Groups Band Together on Labeling of Biosimilars

As the biopharma industry awaits FDA’s guidance on biosimilar naming, brand and generic manufacturers establish positions.

Fight Over Biosimilar Naming Continues

Medicago's new production facility will make plant-based vaccines and therapeutics.

Formulation and Drug Delivery